Log in

NASDAQ:IMMPIMMUTEP LTD/S News Headlines

$0.67
-0.05 (-6.94 %)
(As of 04/5/2020 11:55 AM ET)
Add
Compare
Today's Range
$0.63
Now: $0.67
$0.71
50-Day Range
$0.72
MA: $2.08
$3.03
52-Week Range
$0.53
Now: $0.67
$3.10
Volume276,922 shs
Average Volume563,961 shs
Market Capitalization$26.13 million
P/E RatioN/A
Dividend YieldN/A
Beta2.09

Headlines

IMMUTEP LTD/S (NASDAQ IMMP) News Headlines

Source:
DateHeadline
Immutep down 45% premarket on underwhelming efti dataImmutep down 45% premarket on underwhelming efti data
seekingalpha.com - March 25 at 8:07 AM
The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps DownThe Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps Down
www.benzinga.com - March 25 at 8:07 AM
Immutep’s Partner, EOC Pharma, Reports Completion of Recruitment of Phase I Study of EftiImmutep’s Partner, EOC Pharma, Reports Completion of Recruitment of Phase I Study of Efti
finance.yahoo.com - March 19 at 8:33 PM
Immutep Receives Second IND approval for Efti from US FDAImmutep Receives Second IND approval for Efti from US FDA
finance.yahoo.com - March 9 at 9:09 AM
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roches Tecentriq sBLAThe Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
www.benzinga.com - February 19 at 8:03 AM
Those Who Purchased Immutep (ASX:IMM) Shares Five Years Ago Have A 31% Loss To Show For ItThose Who Purchased Immutep (ASX:IMM) Shares Five Years Ago Have A 31% Loss To Show For It
finance.yahoo.com - December 11 at 10:16 PM
The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J EarningsThe Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings
finance.yahoo.com - October 15 at 11:10 AM
Immutep Reports Positive Final Efficacy Data from TACTI-mel Trial in MelanomaImmutep Reports Positive Final Efficacy Data from TACTI-mel Trial in Melanoma
finance.yahoo.com - October 15 at 11:10 AM
Immutep Limited (ASX:IMM): When Will It Breakeven?Immutep Limited (ASX:IMM): When Will It Breakeven?
finance.yahoo.com - October 12 at 9:38 PM
Immutep Completes A$6M Entitlement OfferImmutep Completes A$6M Entitlement Offer
finance.yahoo.com - August 6 at 9:16 AM
Immutep Raises A$10 Million Via Private Placement and Underwritten Entitlement OfferImmutep Raises A$10 Million Via Private Placement and Underwritten Entitlement Offer
finance.yahoo.com - July 9 at 9:46 AM
Immutep Completes Patient Enrolment of the AIPAC Phase IIb Clinical Trial in Metastatic Breast CancerImmutep Completes Patient Enrolment of the AIPAC Phase IIb Clinical Trial in Metastatic Breast Cancer
finance.yahoo.com - June 25 at 10:10 AM
Immutep Completes Recruitment of Initial Cohort in 1st Line NSCLC Patients for TACTI-002 TrialImmutep Completes Recruitment of Initial Cohort in 1st Line NSCLC Patients for TACTI-002 Trial
finance.yahoo.com - June 13 at 9:45 AM
INSIGHT: First Patient Dosed in the 4th arm called “INSIGHT-004”INSIGHT: First Patient Dosed in the 4th arm called “INSIGHT-004”
finance.yahoo.com - June 6 at 9:38 AM
Immutep nabs patent in U.S. for eftilagimod alpha in cancer; shares up 49% premarketImmutep nabs patent in U.S. for eftilagimod alpha in cancer; shares up 49% premarket
seekingalpha.com - March 22 at 9:47 AM
Immutep Presents Positive IMP761 Preclinical Results at 14th Congress of European Crohn’s and Colitis OrganisationImmutep Presents Positive IMP761 Preclinical Results at 14th Congress of European Crohn’s and Colitis Organisation
finance.yahoo.com - March 7 at 5:45 PM
Immutep doses First Patient in TACTI-002 Phase II TrialImmutep doses First Patient in TACTI-002 Phase II Trial
finance.yahoo.com - March 6 at 9:49 AM
Immutep to Present at Upcoming Industry ConferencesImmutep to Present at Upcoming Industry Conferences
finance.yahoo.com - February 26 at 10:03 AM
Immutep Enters Into Clinical Trial Collaboration, Service and Supply Agreement With CYTLIMICImmutep Enters Into Clinical Trial Collaboration, Service and Supply Agreement With CYTLIMIC
finance.yahoo.com - January 7 at 9:23 AM
Immutep Announces US$5.2 Million Financing Led by U.S. Specialist Healthcare Investor, Altium Capital - GlobeNewswireImmutep Announces US$5.2 Million Financing Led by U.S. Specialist Healthcare Investor, Altium Capital - GlobeNewswire
globenewswire.com - December 21 at 9:25 AM
Form 6-K IMMUTEP Ltd For: Dec 19 - StreetInsider.comForm 6-K IMMUTEP Ltd For: Dec 19 - StreetInsider.com
www.streetinsider.com - December 21 at 9:25 AM
Form 424B5 IMMUTEP Ltd - StreetInsider.comForm 424B5 IMMUTEP Ltd - StreetInsider.com
www.streetinsider.com - December 21 at 9:25 AM
This page was last updated on 4/5/2020 by MarketBeat.com Staff

Featured Article: What are earnings reports?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel